A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance

Détails bibliographiques
Auteurs principaux:	Carballo, S, Blair, E, Watkins, H
Format:	Conference item
Publié:	2004

Documents similaires

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
par: Carballo, S, et autres
Publié: (2004)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
par: Carballo, S, et autres
Publié: (2004)

Identification and functional analysis of cardiac troponin I as a novel disease gene in autosomal dominant familial dilated cardiomyopathy
par: Carballo, S, et autres
Publié: (2006)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
par: Carballo, S, et autres
Publié: (2003)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
par: Carballo, S, et autres
Publié: (2005)

A rare cause of mixed hypertrophic and dilated phenotype cardiomyopathy – the MELAS syndrome
par: Casian Mihnea, et autres
Publié: (2023-09-01)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
par: Carballo, S, et autres
Publié: (2005)

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy.
par: Carballo, S, et autres
Publié: (2009)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
par: Carballo, S, et autres
Publié: (2005)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
par: Robinson, P, et autres
Publié: (2002)

Structures of PKA–phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy
par: Juan Qin, et autres
Publié: (2022-03-01)

Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
par: Yilu Wang, et autres
Publié: (2013-01-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
par: Blair, E, et autres
Publié: (2001)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
par: Blair, E, et autres
Publié: (2000)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
par: Watkins, H
Publié: (2003)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
par: Blair, E, et autres
Publié: (2003)

A novel heterozygous missense MYH7 mutation potentially causes an autosomal dominant form of myosin storage myopathy with dilated cardiomyopathy
par: Niloofar Naderi, et autres
Publié: (2023-10-01)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
par: Suttie, J, et autres
Publié: (2011)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
par: Rayner, JJ, et autres
Publié: (2020)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the <it>MYBPC3 </it>gene
par: Lehrke Stephanie, et autres
Publié: (2008-10-01)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
par: Hamza El Hadi, et autres
Publié: (2023-02-01)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
par: Seitaro Nomura, et autres
Publié: (2023-03-01)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
par: Enrica Chiti, et autres
Publié: (2021-09-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
par: Hudsmith, L, et autres
Publié: (2006)

Dilated cardiomyopathy and the desmin gene.
par: Mayosi, B, et autres
Publié: (2000)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
par: Abdulrazzak, H, et autres
Publié: (2001)

Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
par: Shiv Kumar Viswanathan, et autres
Publié: (2017-01-01)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
par: Robinson, P, et autres
Publié: (2007)

Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations
par: Lina Basel-Vanagaite, et autres
Publié: (2008-06-01)

Intrafamilial phenotypic variability of DNAJB6 mutation associated autosomal dominantly inherited myopathy: a family report and literature review
par: LI Fan, et autres
Publié: (2021-03-01)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
par: Megan J. Puckelwartz, et autres
Publié: (2021-04-01)

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
par: Lakdawala, N, et autres
Publié: (2010)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
par: Jiri Bonaventura, et autres
Publié: (2023-06-01)

Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
par: Val A. Fajardo, et autres
Publié: (2015-08-01)

Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
par: Lorenzo Alamo, et autres
Publié: (2017-06-01)

Digenic Inheritance of LAMA4 and MYH7 Mutations in Patient with Infantile Dilated Cardiomyopathy
par: Atiyeh M Abdallah, et autres
Publié: (2019-01-01)

A Case Study Identified a New Mutation in the TTN Gene for Inherited Hypertrophic Cardiomyopathy
par: Dong J, et autres
Publié: (2025-01-01)

Linked genetic modifiers in hypertrophic cardiomyopathy
par: Ektisham, J, et autres
Publié: (2004)

Desmoplakin mutation underlying autosomal dominant arrhythmogenic cardiomyopathy, palmoplantar keratoderma, and curly hair
par: Colin Kincaid, BS, et autres
Publié: (2023-06-01)

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
par: Marston, S, et autres
Publié: (2009)